(αR,βS)-rel-Bedaquiline is a promising diarylquinoline candidate in clinical development for the treatment of tuberculosis. (αR,βS)-rel-Bedaquiline inhibits mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis.
Melting Point:181-183°C
Solubility:Chloroform, Ethyl Acetate
仕様
Size:5mg
Source Antigen:Synthetic
Grade:Highly Purified
Form:Supplied as a Off-white Solid to Pale Yellow Solid